Sökning: WFRF:(Labrie Fernand)
> (2015-2017) >
Combined Oral Contr...
Combined Oral Contraceptives and Sexual Function in Women-a Double-Blind, Randomized, Placebo-Controlled Trial
-
- Johannesson, Magnus (författare)
- Stockholm School of Economics,Handelshögskolan i Stockholm
-
- Dreber Almenberg, Anna (författare)
- Stockholm School of Economics,Handelshögskolan i Stockholm
-
- Blomberg, Liselott (författare)
- Karolinska Institutet,Karolinska Institutet (SE)
-
visa fler...
-
- Labrie, Fernand (författare)
- EndoCeutics Inc.
-
- Ranehill, Eva (författare)
- Stockholm School of Economics,Handelshögskolan i Stockholm
-
- von Schoultz, B (författare)
- Karolinska Institutet (SE)
-
- Zethraeus, Niklas (författare)
- Karolinska Institutet,Karolinska Institutet (SE)
-
- Lindén Hirschberg, A (författare)
- Karolinska Institutet,Karolinska Institutet (SE)
-
visa färre...
-
(creator_code:org_t)
- 2016-08-15
- 2016
- Engelska.
-
Ingår i: Journal of Clinical Endocrinology and Metabolism. - : Oxford University Press (OUP): Policy B - Oxford Open Option A. - 0021-972X .- 1945-7197. ; 101:11, s. 4046-4053
- Relaterad länk:
-
https://academic.oup...
-
visa fler...
-
https://research.hhs...
-
https://doi.org/10.1...
-
http://kipublication...
-
visa färre...
Abstract
Ämnesord
Stäng
- Context: There is a lack of knowledge about how oral contraceptives may affect sexual function.Objective: To determine whether there is a causal effect of oral contraceptives on sexuality. We hypothesized that a widely used pill impairs sexuality.Design: A double-blind, randomized, placebo-controlled trial. Enrollment began in February 2012 and was completed in August 2015.Setting: Karolinska University Hospital, Stockholm, Sweden.Participants: A total of 340 healthy women, aged 18-35 years, were randomized to treatment, and 332 completed the study.Interventions: A combined oral contraceptive (150 mu g levonorgestrel and 30 mu g ethinylestradiol) or placebo for 3 months of treatment.Main Outcome Measures: The primary outcome was the aggregate score on the Profile of Female Sexual Function (PFSF). Secondary outcomes were the seven domains of the PFSF, the Sexual Activity Log, and the Personal Distress Scale.Results: Overall sexual function was similar in women in the oral contraceptive and placebo groups. The PFSF domains desire (-4.4; 95% confidence interval [CI], -8.49 to -0.38; P =.032), arousal (-5.1; 95% CI, -9.63 to -0.48; P=.030), and pleasure (-5.1; 95% CI, -9.97 to -0.32; P =.036) were significantly reduced in comparison to placebo, whereas orgasm, concern, responsiveness, and self-image were similar between groups. The mean frequency of satisfying sexual episodes and personal distress were also similar between groups.Conclusions: This study shows no negative impact of a levonorgestrel-containing oral contraceptive on overall sexual function, although three of seven sexual function domains were adversely affected.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Reproduktionsmedicin och gynekologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Obstetrics, Gynaecology and Reproductive Medicine (hsv//eng)
Publikations- och innehållstyp
- art (ämneskategori)
- ref (ämneskategori)
Hitta via bibliotek
Till lärosätets databas